Immunogenicity and protective efficacy of influenza vaccination

被引:202
作者
Hannoun, C
Megas, F
Piercy, J
机构
[1] Mapi Values DAubigny, F-69003 Lyon, France
[2] Mapi Values, Adelphi Mill, Macclesfield SK10 5JB, Cheshire, England
[3] Thames Valley Univ, London W5 2BS, England
关键词
influenza vaccination; immunogenicity; protective efficacy;
D O I
10.1016/j.virusres.2004.02.025
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:133 / 138
页数:6
相关论文
共 60 条
[1]   Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic [J].
Ahmed, AH ;
Nicholson, KG ;
NguyenVanTam, JS ;
Pearson, JCG .
EPIDEMIOLOGY AND INFECTION, 1997, 118 (01) :27-33
[2]  
Ahmed AH, 1996, REV MED MICROBIOL, V7, P23
[3]   Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine [J].
Belshe, RB ;
Gruber, WC ;
Mendelman, PM ;
Mehta, HB ;
Mahmood, K ;
Reisinger, K ;
Treanor, J ;
Zangwill, Z ;
Hayden, FG ;
Bernstein, DI ;
Kotloff, K ;
King, J ;
Piedra, PA ;
Block, SL ;
Yan, LH ;
Wolff, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :1133-1137
[4]   Immune response to influenza vaccination in a large healthy elderly population [J].
Bernstein, E ;
Kaye, D ;
Abrutyn, E ;
Gross, P ;
Dorfman, M ;
Murasko, DM .
VACCINE, 1999, 17 (01) :82-94
[5]   Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines - A review and meta-analysis of the literature [J].
Beyer, WEP ;
Palache, AM ;
Osterhaus, ADME .
CLINICAL DRUG INVESTIGATION, 1998, 15 (01) :1-12
[6]   Protection against influenza after annually repeated vaccination -: A meta-analysis of serologic and field studies [J].
Beyer, WEP ;
de Bruijn, IA ;
Palache, AM ;
Westendorp, RGJ ;
Osterhaus, ADME .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (02) :182-188
[7]   ANTIBODY INDUCTION BY INFLUENZA VACCINES IN THE ELDERLY - A REVIEW OF THE LITERATURE [J].
BEYER, WEP ;
PALACHE, AM ;
BALJET, M ;
MASUREL, N .
VACCINE, 1989, 7 (05) :385-394
[8]   Humoral immune response to influenza vaccination in patients from high risk groups [J].
Brydak, LB ;
Machala, M .
DRUGS, 2000, 60 (01) :35-53
[9]  
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1
[10]  
*CDC, 2002, EP PREV VACC PREV DI